
Lupin, SteinCares enter into agreement for ranibizumab biosimilar in Latin America
SteinCares will handle all regulatory filings, registrations and commercialization of Ranibizumab in Latin America, while Lupin will be responsible for manufacturing the same. Lupin has entered into a license and supply agreement with SteinCares, a …